Homotypic Dengue Virus Reinfections in Nicaraguan Children

Journal of Infectious Diseases

Volumn 214, Issue 7, 2016, Pages 986-993

  Waggoner, Jesse J ^a   Balmaseda, Angel ^d   Gresh, Lionel ^f   Sahoo, Malaya K ^b   Montoya, Magelda ^c   Wang, Chunling ^c   Abeynayake, Janaki ^b   Kuan, Guillermina ^e   Pinsky, Benjamin A ^a,b   Harris, Eva ^c  

^a Division of Infectious Diseases and Geographic Medicine   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d National Virology Laboratory   (Mexico)

^e Ministry of Health   (Nicaragua)

^f Sustainable Sciences Institute   (Nicaragua)

Author keywords

dengue immunity; dengue virus; homotypic reinfection; repeat infection

Indexed keywords

ADOLESCENT; ARTICLE; CASE REPORT; CHILD; CHILD HEALTH; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DENGUE VIRUS 3; FEMALE; FEVER; HUMAN; HUMORAL IMMUNITY; MALE; NICARAGUAN; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REINFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROTYPE; SYMPTOM; VIRUS TRANSMISSION; CLASSIFICATION; DENGUE VIRUS; GENETICS; GENOTYPE; IMMUNOLOGY; ISOLATION AND PURIFICATION; NICARAGUA; PROSPECTIVE STUDY; RECURRENT DISEASE; RETROSPECTIVE STUDY; SERUM; VIROLOGY;

VIRUS RNA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE VIRUS; FEMALE; GENOTYPE; HUMANS; MALE; NICARAGUA; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RECURRENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROGROUP; SERUM;

EID: 84994112340     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw099     Document Type: Article

References (37)

1. Guzman MG, Harris E. Dengue. Lancet 2015; 385:453-65.
2. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1:30-50.
3. Halstead SB. Etiologies of the experimental dengues of Siler and Simmons. Am J Trop Med Hyg 1974; 23:974-82.
4. Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 1990; 42:179-84.
5. Zompi S, Harris E. Animal models of dengue virus infection. Viruses 2012; 4:62-82.
6. Gibbons RV, Kalanarooj S, Jarman RG, et al. Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences. Am J Trop Med Hyg 2007; 77:910-3.
7. Liebman KA, Stoddard ST, Morrison AC, et al. Spatial dimensions of dengue virus transmission across interepidemic and epidemic periods in Iquitos, Peru (1999-2003). PLoS Negl Trop Dis 2012; 6:e1472.
8. Anderson KB, Gibbons RV, Cummings DA, et al. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. J Infect Dis 2014; 209:360-8.
9. Montoya M, Gresh L, Mercado JC, et al. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl Trop Dis 2013; 7:e2357.
10. Endy TP, Chunsuttiwat S, Nisalak A, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:40-51.
11. Gordon A, Kuan G, Mercado JC, et al. The Nicaraguan pediatric dengue cohort study: incidence of inapparent and symptomatic dengue virus infections, 2004-2010. PLoS Negl Trop Dis 2013; 7:e2462.
12. Endy TP, Nisalak A, Chunsuttitwat S, et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 2004; 189:990-1000.
13. Sharp TM, Hunsperger E, Munoz-Jordan JL, Margolis HS, Tomashek KM. Sequential episodes of dengue-Puerto Rico, 2005-2010. Am J Trop Med Hyg 2014; 91:235-9.
14. Sirivichayakul C, Sabchareon A, Limkittikul K, Yoksan S. Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand. Virol J 2014; 11:48.
15. Kuan G, Gordon A, AvilesW, et al. The Nicaraguan pediatric dengue cohort study: study design, methods, use of information technology, and extension to other infectious diseases. Am J Epidemiol 2009; 170:120-9.
16. OhAinle M, Balmaseda A, Macalalad AR, et al. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 2011; 3:114ra28.
17. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptasepolymerase chain reaction. J Clin Micobiol 1992; 30:545-51.
18. Waggoner JJ, Abeynayake J, Sahoo MK, et al. Comparison of the FDA-approved CDC DENV-1-4 real-time reverse transcription-PCR with a laboratory-developed assay for dengue virus detection and serotyping. J ClinMicrobiol 2013; 51:3418-20.
19. Balmaseda A, Sandoval E, Perez L, Gutierrez CM, Harris E. Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am J Trop Med Hyg 1999; 61:893-7.
20. Gutierrez G, Gresh L, Perez MA, et al. Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitions. PLoS Negl Trop Dis 2013; 7:e2385.
21. Waggoner JJ, Abeynayake J, Balassiano I, et al. A multiplex nucleic acid amplification test for the diagnosis of dengue, malaria, and leptospirosis. J Clin Microbiol 2014; 52:2011-8.
22. Chien L, Liao T, Shu P, Huang J, Gubler DJ, Chang GJ. Development of real-time reverse transcriptase PCR assays to detect and serotype dengue viruses. J Clin Micobiol 2006; 44:1295.
23. Balmaseda A, Hammond SN, Tellez Y, et al. High seroprevalence of antibodies against dengue virus in a prospective study of schoolchildren in Managua, Nicaragua. Trop Med Int Health 2006; 11:935-42.
24. Fernandez RJ, Vazquez S. Serological diagnosis of dengue by an ELISA inhibition method (EIM). Mem Inst Oswaldo Cruz 1990; 85:347-51.
25. Katzelnick LC, Montoya M, Gresh L, Balmaseda A, Harris E. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort. Proc Natl Acad Sci USA 2016; 113:728-33.
26. Mattia K, Puffer BA, Williams KL, et al. Dengue reporter virus particles for measuring neutralizing antibodies against each of the four dengue serotypes. PLoS One 2011; 6:e27252.
27. Webster DP, Farrar J, Rowland-Jones S. Progress towards a dengue vaccine. Lancet Infect Dis 2009; 9:678-87.
28. Halstead SB, Shotwell H, Casals J. Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection. J Infect Dis 1973; 128:15-22.
29. Scherer WF, Breakenridge FA, Dickerman RW. Cross-protection studies and search for subclinical disease in new world monkeys infected sequentially with different immunologic types of Dengue viruses. Am J Epidemiol 1972; 95:67-79.
30. Whitehead RH, Chaicumpa V, Olson LC, Russell PK. Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg 1970; 19:94-102.
31. Bernardo L, Izquierdo A, Prado I, et al. Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. Clin Vaccine Immunol 2008; 15:439-46.
32. Waggoner JJ, Abeynayake J, Sahoo MK, et al. Development of an internally controlled real-time reverse transcriptase PCR assay for pan-dengue virus detection and comparison of four molecular dengue virus detection assays. J Clin Microbiol 2013; 51:2172-81.
33. Standish K, Kuan G, Aviles W, Balmaseda A, Harris E. High dengue case capture rate in four years of a cohort study in Nicaragua compared to national surveillance data. PLoS Negl Trop Dis 2010; 4:e633.
34. Reiner RC Jr., Stoddard ST, Forshey BM, et al. Time-varying, serotype-specific force of infection of dengue virus. Proc Natl Acad Sci USA 2014; 111:E2694-702.
35. Singh K, Lale A, Eong Ooi E, et al. A prospective clinical study on the use of reverse transcription-polymerase chain reaction for the early diagnosis of Dengue fever. J Mol Diagn 2006; 8:613-6; quiz 7-20.
36. Johnson FB. Transport of viral specimens. Clin Microbiol Rev 1990; 3:120-31.
37. Levin MJ, Leventhal S, Masters HA. Factors influencing quantitative isolation of varicella-zoster virus. J Clin Microbiol 1984; 19:880-3.